A new agreement will support health care in 10 African countries and offer diagnostic tests and protective equipment for people who need help the most.
The EIB has a potential portfolio of 22 European companies working on promising projects in vaccines, treatments and diagnostics, representing a total investment of about €770 million.
To help find treatments for the coronavirus, we are working with companies such as Nuritas, which uses artificial intelligence and DNA analysis to improve healthcare.
We cooperate with many important foundations and groups on vaccine research, diagnostic services, the combat against malaria and the drive to improve healthcare in low-income parts of the world.
What parts of society will be transformed forever? In our new podcast on the coronavirus, bank experts examine what the crisis means for education, digitalisation, urban mobility and medicine.
The Spanish firm Ecoalf is using plastic bottles from the sea, nylon from old fishnets, discarded carpets, used yarn and other products to make new clothes.
Can everyone get access to a quick and reliable internet service? Andres Gavira Etzel, an EIB engineer, explains the advantages of optical fibre and why it works so well over long distances.
Small companies in the Western Balkans have a hard time getting loans. The Western Balkans Enterprise Development and Innovation Facility is solving this problem.
Startups are important sources of employment and innovation. Learn what these small companies need to grow and how governments can be their key partners.
Highlights from the EIB Board Meeting, 15 May 2020
